242 related articles for article (PubMed ID: 37728647)
1. [Diagnosis and Treatment of IgA Nephropathy-2023].
Schimpf J; Kronbichler A; Windpessl M; Zitt E; Eller K; Säemann MD; Lhotta K; Rudnicki M
Wien Klin Wochenschr; 2023 Aug; 135(Suppl 5):621-627. PubMed ID: 37728647
[TBL] [Abstract][Full Text] [Related]
2. IgA nephropathy.
Stamellou E; Seikrit C; Tang SCW; Boor P; Tesař V; Floege J; Barratt J; Kramann R
Nat Rev Dis Primers; 2023 Nov; 9(1):67. PubMed ID: 38036542
[TBL] [Abstract][Full Text] [Related]
3. A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges.
Gutiérrez E; Carvaca-Fontán F; Luzardo L; Morales E; Alonso M; Praga M
Nephron; 2020; 144(11):555-571. PubMed ID: 32818944
[TBL] [Abstract][Full Text] [Related]
4. Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case.
Cambier A; Dossier C; Hogan J; Baudouin V; Maisin A; Couderc A; Kwon T; Gleeson PJ; Monteiro RC
Pediatr Nephrol; 2022 Jul; 37(7):1597-1603. PubMed ID: 34997322
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
Taylor S; Pieri K; Nanni P; Tica J; Barratt J; Didangelos A
J Autoimmun; 2019 Dec; 105():102309. PubMed ID: 31402200
[TBL] [Abstract][Full Text] [Related]
6. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
Cassol CA; Bott C; Nadasdy GM; Alberton V; Malvar A; Nagaraja HN; Nadasdy T; Rovin BH; Satoskar AA
Nephrol Dial Transplant; 2020 Dec; 35(12):2123-2129. PubMed ID: 31369128
[TBL] [Abstract][Full Text] [Related]
7. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
8. IgA nephropathy in adults-treatment standard.
Gleeson PJ; O'Shaughnessy MM; Barratt J
Nephrol Dial Transplant; 2023 Oct; 38(11):2464-2473. PubMed ID: 37418237
[TBL] [Abstract][Full Text] [Related]
9. IgA Nephropathy: Core Curriculum 2021.
Pattrapornpisut P; Avila-Casado C; Reich HN
Am J Kidney Dis; 2021 Sep; 78(3):429-441. PubMed ID: 34247883
[TBL] [Abstract][Full Text] [Related]
10. Sparsentan: the first and only non-immunosuppressive therapy for the reduction of proteinuria in IgA nephropathy.
Trachtman H; Komers R; Inrig J
Expert Rev Clin Immunol; 2024 Jun; 20(6):571-576. PubMed ID: 38362830
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals].
; Jiang XY
Zhonghua Er Ke Za Zhi; 2007 Apr; 45(4):272-8. PubMed ID: 17706064
[TBL] [Abstract][Full Text] [Related]
12. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
13. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
14. The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy.
Sanchez-Russo L; Rajasekaran A; Bin S; Faith J; Cravedi P
Kidney360; 2022 Sep; 3(9):1630-1639. PubMed ID: 36245664
[TBL] [Abstract][Full Text] [Related]
15. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S
Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620
[TBL] [Abstract][Full Text] [Related]
17. Treatment of progressive IgA nephropathy: an update.
Wang W; Chen N
Contrib Nephrol; 2013; 181():75-83. PubMed ID: 23689569
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and classification of IgA nephropathy.
Yu HH; Chiang BL
Autoimmun Rev; 2014; 13(4-5):556-9. PubMed ID: 24434362
[TBL] [Abstract][Full Text] [Related]
19. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
[TBL] [Abstract][Full Text] [Related]
20. Treatment of IgA nephropathy.
Barratt J; Feehally J
Kidney Int; 2006 Jun; 69(11):1934-8. PubMed ID: 16641928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
